VANI 8-K: Fda approval
Vivani Medical
Filed with the SEC on · accession 0001753926-26-002108
VANI filed a 8-K (current report) with the SEC on Nov 12, 2026. Vivani Medical announced positive top-line results from its SLIM-1 Phase 1 trial of NPM-139, an investigational semaglutide implant for chronic weight management, showing no treatment-related adverse events and a favorable pharmacokinetic profile. The stock moved -20.3% by the first close after the filing.
Summary of the filing
Vivani Medical announced positive top-line results from its SLIM-1 Phase 1 trial of NPM-139, an investigational semaglutide implant for chronic weight management, showing no treatment-related adverse events and a favorable pharmacokinetic profile. The company plans to advance NPM-139 into a Phase 2 dose-ranging weight maintenance trial anticipated to begin in 2027.
Key details
How VANI stock reacted
Close before
$1.13
Nov 11, 2026
First close after
-20.27%
$0.90
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for VANI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VANI?
Click hereFrequently asked questions
What did VANI file with the SEC on Nov 12, 2026?
VANI filed a 8-K (Fda approval). Vivani Medical announced positive top-line results from its SLIM-1 Phase 1 trial of NPM-139, an investigational semaglutide implant for chronic weight management, showing no treatment-related adverse events and a favorable pharmacokinetic profile. The company plans to advance NPM-139 into a Phase 2 dose-ranging weight maintenance trial anticipated to begin in 2027.
What does a fda approval mean for VANI stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did VANI stock react to this filing?
VANI closed at $1.13 before the filing and $0.90 on Nov 12, 2026 (-20.27%).
Other VANI SEC filings
Get alerts when VANI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days